SENZAR ASSET MANAGEMENT, LLC current holdings: USA Other Stocks
SENZAR ASSET MANAGEMENT, LLC reported $186.75 billion in shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), 25 positions, in its Form 13F for the quarter ended 2016-09-30; the largest are EXPRESS SCRIPTS HLDG CO, AETNA INC NEW, ENDOLOGIX INC.
- EXPRESS SCRIPTS HLDG CO: Country of operation —; Class COM; Shares 297,700; Value $20,996,781,000.
- AETNA INC NEW: Country of operation —; Class COM; Shares 123,600; Value $14,269,620,000.
- ENDOLOGIX INC: Country of operation —; Class COM; Shares 1,087,700; Value $13,922,560,000.
- ALLERGAN PLC: Country of operation —; Class SHS; Shares 58,500; Value $13,473,135,000.
Form 13F-HR as filed (SEC CIK 1579853): quarter ended 2016-09-30, filed 2016-11-14. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.
| Stock | Country of operation | Class | Shares | Value | Quarter end | Filed |
|---|
EXPRESS SCRIPTS HLDG CO
CUSIP 30219G108 | | COM | 297,700 | $20,996,781,000 | 2016-09-30 | 2016-11-14 |
|---|
AETNA INC NEW
CUSIP 00817Y108 | | COM | 123,600 | $14,269,620,000 | 2016-09-30 | 2016-11-14 |
|---|
ENDOLOGIX INC
CUSIP 29266S106 | | COM | 1,087,700 | $13,922,560,000 | 2016-09-30 | 2016-11-14 |
|---|
ALLERGAN PLC
CUSIP G0177J108 | | SHS | 58,500 | $13,473,135,000 | 2016-09-30 | 2016-11-14 |
|---|
VALEANT PHARMACEUTICALS INTL
CUSIP 91911K102 | | COM | 488,900 | $12,002,495,000 | 2016-09-30 | 2016-11-14 |
|---|
MOMENTA PHARMACEUTICALS INC
CUSIP 60877T100 | | COM | 962,098 | $11,246,926,000 | 2016-09-30 | 2016-11-14 |
|---|
RETROPHIN INC
CUSIP 761299106 | | COM | 470,789 | $10,536,258,000 | 2016-09-30 | 2016-11-14 |
|---|
MYLAN N V
CUSIP N59465109 | | SHS EURO | 273,500 | $10,425,820,000 | 2016-09-30 | 2016-11-14 |
|---|
ALDER BIOPHARMACEUTICALS INC
CUSIP 014339105 | | COM | 296,670 | $9,721,876,000 | 2016-09-30 | 2016-11-14 |
|---|
CORIUM INTL INC
CUSIP 21887L107 | | COM | 1,603,066 | $9,025,262,000 | 2016-09-30 | 2016-11-14 |
|---|
TESARO INC
CUSIP 881569107 | | COM | 84,300 | $8,450,232,000 | 2016-09-30 | 2016-11-14 |
|---|
ADEPTUS HEALTH INC
CUSIP 006855100 | | CL A | 163,700 | $7,047,285,000 | 2016-09-30 | 2016-11-14 |
|---|
CONCERT PHARMACEUTICALS INC
CUSIP 206022105 | | COM | 572,388 | $5,786,843,000 | 2016-09-30 | 2016-11-14 |
|---|
FOAMIX PHARMACEUTICALS LTD
CUSIP M46135105 | | SHS | 523,397 | $4,846,656,000 | 2016-09-30 | 2016-11-14 |
|---|
ARRAY BIOPHARMA INC
CUSIP 04269X105 | | COM | 627,100 | $4,232,925,000 | 2016-09-30 | 2016-11-14 |
|---|
ACORDA THERAPEUTICS INC
CUSIP 00484M106 | | COM | 191,500 | $3,998,520,000 | 2016-09-30 | 2016-11-14 |
|---|
INOTEK PHARMACEUTICALS CORP
CUSIP 45780V102 | | COM | 413,622 | $3,921,137,000 | 2016-09-30 | 2016-11-14 |
|---|
TANDEM DIABETES CARE INC
CUSIP 875372104 | | COM | 455,411 | $3,488,448,000 | 2016-09-30 | 2016-11-14 |
|---|
AERIE PHARMACEUTICALS INC
CUSIP 00771V108 | | COM | 92,200 | $3,479,628,000 | 2016-09-30 | 2016-11-14 |
|---|
AVIRAGEN THERAPEUTICS INC
CUSIP 053761102 | | COM | 1,779,976 | $3,417,554,000 | 2016-09-30 | 2016-11-14 |
|---|
RIGEL PHARMACEUTICALS INC
CUSIP 766559603 | United States | COM NEW | 907,203 | $3,329,435,000 | 2016-09-30 | 2016-11-14 |
|---|
NEURODERM LTD
CUSIP M74231107 | | ORD SHS | 171,300 | $3,167,337,000 | 2016-09-30 | 2016-11-14 |
|---|
ARENA PHARMACEUTICALS INC
CUSIP 040047102 | | COM | 1,637,891 | $2,866,309,000 | 2016-09-30 | 2016-11-14 |
|---|
ZOGENIX INC
CUSIP 98978L204 | | COM NEW | 137,900 | $1,576,197,000 | 2016-09-30 | 2016-11-14 |
|---|
PARATEK PHARMACEUTICALS INC
CUSIP 699374302 | United States | COM | 117,019 | $1,522,417,000 | 2016-09-30 | 2016-11-14 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |